SSII SS Innovations International, Inc.
Healthcare$3.77+0.00%OpenMarket Cap: $755.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
13.98
P/S
16.07
EV/EBITDA
-181.50
DCF Value
$-32.11
FCF Yield
-2.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.4%
Operating Margin
-12.7%
Net Margin
-20.7%
ROE
-23.0%
ROA
-11.1%
ROIC
-9.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $11.1M | 45.0% | $-3.7M | $-3.6M | $— | — |
| Q4 null | $14.5M | 43.9% | $-735.0K | $-2.5M | $— | — |
| FY null | $42.5M | 46.0% | $-8.2M | $-12.1M | $— | — |
| Q3 null | $12.8M | 48.1% | $-1.8M | $-3.7M | $— | — |
| Q2 null | $10.0M | 59.1% | $97.0K | $-256.7K | $— | — |
| Q1 null | $5.1M | 21.2% | $-5.9M | $-5.7M | $— | — |
| Q4 null | $5.6M | 53.9% | $-7.6M | $-7.5M | $— | — |
| FY null | $20.6M | 40.9% | $-19.0M | $-19.2M | $— | — |
| Q3 null | $4.4M | 52.8% | $-3.2M | $-3.2M | $— | — |
| Q2 null | $4.4M | 16.8% | $-2.8M | $-2.9M | $— | — |
| Q1 null | $6.9M | 42.3% | $-2.7M | $-2.8M | $— | — |
| Q4 2023 | $1.4M | -13.3% | $-15.5M | $-16.1M | $-0.09 | — |